- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 271/07 - 1,2,4-OxadiazolesHydrogenated 1,2,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
Patent holdings for IPC class C07D 271/07
Total number of patents in this class: 167
10-year publication summary
|
12
|
19
|
14
|
9
|
12
|
10
|
5
|
13
|
10
|
4
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Theravance Biopharma R&D IP, LLC | 453 |
6 |
| Farmington Pharma Development | 7 |
5 |
| Oryzon Genomics S.A. | 108 |
5 |
| Janssen Pharmaceutica N.V. | 3358 |
4 |
| Novassay S.A. | 10 |
4 |
| Romark Laboratories L.C. | 49 |
4 |
| Bayer Intellectual Property GmbH | 2454 |
3 |
| Bayer Cropscience AG | 1983 |
3 |
| Bayer Pharma AG | 1048 |
3 |
| King Faisal University | 921 |
3 |
| The Board of Regents of the University of Texas System | 2234 |
3 |
| Calico Life Sciences LLC | 104 |
3 |
| Bristol-myers Squibb Company | 4826 |
2 |
| BASF SE | 21098 |
2 |
| Boehringer Ingelheim International GmbH | 4636 |
2 |
| Abbvie Inc. | 1817 |
2 |
| Takeda Pharmaceutical Company Limited | 2721 |
2 |
| Vertex Pharmaceuticals Incorporated | 1630 |
2 |
| Northwestern University | 3457 |
2 |
| CHDI Foundation, Inc. | 106 |
2 |
| Other owners | 105 |